Floxuridine (FUDR)
Sponsors
Memorial Sloan Kettering Cancer Center, Corewell Health West, Benaroya Research Institute, Sunnybrook Health Sciences Centre
Conditions
CholangiocarcinomaCholangiocellular CarcinomaCholangiolar CarcinomaColorectal Adenocarcinoma Metastatic in the LiverColorectal Adenocarcinoma Metastatic to the LiverColorectal CancerIntrahepatic CholangiocarcinomaLiver Metastases
Phase 2
Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC)
CompletedNCT01862315
Start: 2013-05-01End: 2025-03-18Updated: 2026-07-01
Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver
WithdrawnNCT03069950
Start: 2017-02-28End: 2019-05-16Updated: 2019-05-21
A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma
CompletedNCT03693807
Start: 2018-10-18End: 2024-06-27Updated: 2026-02-06
Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases
Active, not recruitingNCT03856658
Start: 2019-02-05End: 2028-12-01Updated: 2026-07-16
A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma
NCT04668976
Start: 2020-11-25End: 2024-12-31Target: 100Updated: 2020-12-21
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
RecruitingNCT04891289
Start: 2021-05-07End: 2027-05-01Target: 164Updated: 2026-08-17
Hepatic Arterial Infusion Chemotherapy in Patients With Inoperable Colorectal Cancer Liver Metastasis
RecruitingNCT07764497
Start: 2014-07-01End: 2036-12-01Target: 200Updated: 2026-08-14